{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:19:52Z","timestamp":1767136792432,"version":"build-2238731810"},"publisher-location":"New York, NY","reference-count":51,"publisher":"Springer US","isbn-type":[{"value":"9781071621271","type":"print"},{"value":"9781071621288","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2128-8_5","type":"book-chapter","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T05:03:21Z","timestamp":1645765401000},"page":"49-62","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Measurement of Fatty Acid Oxidation in Mammalian Cells"],"prefix":"10.1007","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhai","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1194\/jlr.R800079-JLR200","volume":"50","author":"SJ Wakil","year":"2009","unstructured":"Wakil SJ, Abu-Elheiga LA (2009) Fatty acid metabolism: target for metabolic syndrome. J Lipid Res 50:S138\u2013S143","journal-title":"J Lipid Res"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","volume":"78","author":"SM Houten","year":"2016","unstructured":"Houten SM, Violante S, Ventura FV, Wanders RJA (2016) The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders. Annu Rev Physiol 78:23\u201344","journal-title":"Annu Rev Physiol"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ymgme.2004.08.016","volume":"83","author":"RJA Wanders","year":"2004","unstructured":"Wanders RJA (2004) Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol Genet Metab 83:16\u201327","journal-title":"Mol Genet Metab"},{"key":"5_CR4","first-page":"979","volume":"58","author":"S Ushikubo","year":"1996","unstructured":"Ushikubo S, Aoyama T, Kamijo T et al (1996) Molecular characterization of mitochondrial trifunctional protein deficiency: formation of the enzyme complex is important for stabilization of both \u03b1- and \u03b2-subunits. Am J Hum Genet 58:979\u2013988","journal-title":"Am J Hum Genet"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1042\/bst0280177","volume":"28","author":"S Eaton","year":"2000","unstructured":"Eaton S, Bursby T, Middleton B et al (2000) The mitochondrial trifunctional protein: centre of a \u03b2-oxidation metabolon? Biochem Soc Trans 28:177\u2013182","journal-title":"Biochem Soc Trans"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12482-1","volume":"10","author":"JW Miklas","year":"2019","unstructured":"Miklas JW, Clark E, Levy S et al (2019) TFPa\/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes. Nat Commun 10:1\u201321","journal-title":"Nat Commun"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1373\/clinchem.2005.062000","volume":"52","author":"AM Das","year":"2006","unstructured":"Das AM, Illsinger S, L\u00fccke T et al (2006) Isolated mitochondrial long-chain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene. Clin Chem 52:530\u2013534","journal-title":"Clin Chem"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbabio.2010.10.022","volume":"1807","author":"LS Pike","year":"2011","unstructured":"Pike LS, Smift AL, Croteau NJ et al (2011) Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta Bioenerg 1807:726\u2013734","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1158\/0008-5472.CAN-14-2676","volume":"75","author":"EA Lee","year":"2015","unstructured":"Lee EA, Angka L, Rota SG et al (2015) Targeting mitochondria with avocatin B induces selective leukemia cell death. Cancer Res 75:2478\u20132488","journal-title":"Cancer Res"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","volume":"13","author":"A Carracedo","year":"2013","unstructured":"Carracedo A, Cantley LC, Pandolfi PP (2013) Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 13:227\u2013232","journal-title":"Nat Rev Cancer"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature11066","volume":"485","author":"SM Jeon","year":"2012","unstructured":"Jeon SM, Chandel NS, Hay N (2012) AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485:661\u2013665","journal-title":"Nature"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00394-005-0576-5","volume":"45","author":"ES Shin","year":"2006","unstructured":"Shin ES, Cho SY, Lee EH et al (2006) Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine. Eur J Nutr 45:159\u2013164","journal-title":"Eur J Nutr"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/bj3610417","volume":"361","author":"FM Vaz","year":"2002","unstructured":"Vaz FM, Wanders RJA (2002) Carnitine biosynthesis in mammals. Biochem J 361:417\u2013429","journal-title":"Biochem J"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"e2226","DOI":"10.1038\/cddis.2016.132","volume":"7","author":"Q Qu","year":"2016","unstructured":"Qu Q, Zeng F, Liu X et al (2016) Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death Dis 7:e2226\u2013e2226","journal-title":"Cell Death Dis"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1113\/jphysiol.2004.081679","volume":"565","author":"AC Smith","year":"2005","unstructured":"Smith AC, Bruce CR, Dyck DJ (2005) AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle. J Physiol 565:537\u2013546","journal-title":"J Physiol"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1432-1033.1995.tb20498.x","volume":"229","author":"JM Corton","year":"1995","unstructured":"Corton JM, Gillespie JG, Hawley SA, Hardie DG (1995) 5-aminoimidazole-4-carboxamide ribonucleoside: a specific method for activating AMP-activated protein kinase in intact cells. Eur J Biochem 229:558\u2013565","journal-title":"Eur J Biochem"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10555-011-9319-7","volume":"30","author":"AJS Houben","year":"2011","unstructured":"Houben AJS, Moolenaar WH (2011) Autotaxin and LPA receptor signaling in cancer. Cancer Metastasis Rev 30:557\u2013565","journal-title":"Cancer Metastasis Rev"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","volume":"73","author":"Z Li","year":"2016","unstructured":"Li Z, Zhang H (2016) Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci 73:377\u2013392","journal-title":"Cell Mol Life Sci"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","volume":"27","author":"T Wang","year":"2018","unstructured":"Wang T, Fahrmann JF, Lee H et al (2018) JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance. Cell Metab 27:136\u2013150.e5","journal-title":"Cell Metab"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.celrep.2016.02.004","volume":"14","author":"JH Park","year":"2016","unstructured":"Park JH, Vithayathil S, Kumar S et al (2016) Fatty acid oxidation-driven Src links mitochondrial energy reprogramming and oncogenic properties in triple-negative breast cancer. Cell Rep 14:2154\u20132165","journal-title":"Cell Rep"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.2882","volume":"18","author":"K Ito","year":"2012","unstructured":"Ito K, Carracedo A, Weiss D et al (2012) A PML-PPAR-\u03b4 pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. Nat Med 18:1350\u20131358","journal-title":"Nat Med"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1021\/jm101360s","volume":"55","author":"C Pirat","year":"2012","unstructured":"Pirat C, Farce A, Leb\u00e8gue N et al (2012) Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators. J Med Chem 55:4027\u20134061","journal-title":"J Med Chem"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.semcdb.2012.01.003","volume":"23","author":"L l C Poulsen","year":"2012","unstructured":"Poulsen L l C, Siersb\u00e6k M, Mandrup S (2012) PPARs: fatty acid sensors controlling metabolism. Semin Cell Dev Biol 23:631\u2013639","journal-title":"Semin Cell Dev Biol"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"G739","DOI":"10.1152\/ajpgi.00432.2010","volume":"301","author":"MS Sozio","year":"2011","unstructured":"Sozio MS, Lu C, Zeng Y et al (2011) Activated AMPK inhibits PPAR-\u03b1 and PPAR-\u03b3 transcriptional activity in hepatoma cells. Am J Physiol Gastrointest Liver Physiol 301:G739\u2013G747","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","volume":"435","author":"Y Ma","year":"2018","unstructured":"Ma Y, Temkin SM, Hawkridge AM et al (2018) Fatty acid oxidation: an emerging facet of metabolic transformation in cancer. Cancer Lett 435:92\u2013100","journal-title":"Cancer Lett"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2337\/db08-0281","volume":"57","author":"DM Muoio","year":"2008","unstructured":"Muoio DM, Newgard CB (2008) Fatty acid oxidation and insulin action: when less is more. Diabetes 57:1455\u20131456","journal-title":"Diabetes"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/diacare.15.6.773","volume":"15","author":"JE Foley","year":"1992","unstructured":"Foley JE (1992) Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus. Diabetes Care 15:773\u2013784","journal-title":"Diabetes Care"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrendo.2016.15","volume":"12","author":"G Umpierrez","year":"2016","unstructured":"Umpierrez G, Korytkowski M (2016) Diabetic emergencies-ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol 12:222\u2013232","journal-title":"Nat Rev Endocrinol"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CDL et al (2010) Myocardial fatty acid metabolism in health and disease. Physiol Rev 90:207\u2013258","journal-title":"Physiol Rev"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1152\/ajpgi.00521.2005","volume":"290","author":"JK Reddy","year":"2006","unstructured":"Reddy JK, Rao MS (2006) Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 290:852\u2013858","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"13992","DOI":"10.1021\/acs.est.9b05131","volume":"53","author":"X He","year":"2019","unstructured":"He X, Gao J, Hou H et al (2019) Inhibition of mitochondrial fatty acid oxidation contributes to development of nonalcoholic fatty liver disease induced by environmental cadmium exposure. Environ Sci Technol 53:13992\u201314000","journal-title":"Environ Sci Technol"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nm.4055","volume":"22","author":"R Camarda","year":"2016","unstructured":"Camarda R, Zhou AY, Kohnz RA et al (2016) Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer. Nat Med 22:427\u2013432","journal-title":"Nat Med"},{"key":"5_CR33","first-page":"708","volume":"48","author":"A Kumps","year":"2002","unstructured":"Kumps A, Duez P, Mardens Y (2002) Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: a comprehensive table. Clin Chem 48:708\u2013717","journal-title":"Clin Chem"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1373\/clinchem.2003.022178","volume":"49","author":"DH Chace","year":"2003","unstructured":"Chace DH, Kalas TA, Naylor EW (2003) Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 49:1797\u20131817","journal-title":"Clin Chem"},{"key":"5_CR35","first-page":"25.3.1","volume":"2014","author":"GW Rogers","year":"2014","unstructured":"Rogers GW, Nadanaciva S, Swiss R et al (2014) Assessment of fatty acid beta oxidation in cells and isolated mitochondria. Curr Protoc Toxicol 2014:25.3.1\u201325.3.19","journal-title":"Curr Protoc Toxicol"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ni.3366","volume":"17","author":"M Nomura","year":"2016","unstructured":"Nomura M, Liu J, Rovira II et al (2016) Fatty acid oxidation in macrophage polarization. Nat Immunol 17:216\u2013217","journal-title":"Nat Immunol"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1203\/00006450-198210000-00015","volume":"16","author":"JM Saudubray","year":"1982","unstructured":"Saudubray JM, Coud\u00e9 FX, Demaugre F et al (1982) Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation. Pediatr Res 16:877\u2013881","journal-title":"Pediatr Res"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/B978-0-12-416618-9.00020-0","volume":"542","author":"FK Huynh","year":"2014","unstructured":"Huynh FK, Green MF, Koves TR, Hirschey MD (2014) Measurement of fatty acid oxidation rates in animal tissues and cell lines. Methods Enzymol 542:391\u2013405","journal-title":"Methods Enzymol"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1126\/science.6857268","volume":"221","author":"WJ Rhead","year":"1983","unstructured":"Rhead WJ, Amendt BA, Fritchman KS, Felts SJ (1983) Dicarboxylic aciduria: deficient [1-14C]octanoate oxidation and medium-chain acyl-CoA dehydrogenase in fibroblasts. Science 221:71\u201373","journal-title":"Science"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/BF01799333","volume":"13","author":"NJ Manning","year":"1990","unstructured":"Manning NJ, Olpin SE, Pollitt RJ, Webley J (1990) A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts. J Inherit Metab Dis 13:58\u201368","journal-title":"J Inherit Metab Dis"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0885-4505(86)90080-0","volume":"35","author":"JH Veerkamp","year":"1986","unstructured":"Veerkamp JH, van Moerkerk HTB, Glatz JFC et al (1986) 14CO2 production is no adequate measure of [14C]fatty acid oxidation. Biochem Med Metab Biol 35:248\u2013259","journal-title":"Biochem Med Metab Biol"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1172\/JCI112808","volume":"79","author":"A Moon","year":"1987","unstructured":"Moon A, Rhead WJ (1987) Complementation analysis of fatty acid oxidation disorders. J Clin Invest 79:59\u201364","journal-title":"J Clin Invest"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.18632\/oncotarget.6757","volume":"7","author":"H Shao","year":"2016","unstructured":"Shao H, Mohamed EM, Xu GG et al (2016) Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer. Oncotarget 7:3832\u20133846","journal-title":"Oncotarget"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV et al (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17:1498\u20131503","journal-title":"Nat Med"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature14362","volume":"520","author":"S Schoors","year":"2015","unstructured":"Schoors S, Bruning U, Missiaen R et al (2015) Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature 520:192\u2013197","journal-title":"Nature"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cmet.2018.07.016","volume":"28","author":"J Kalucka","year":"2018","unstructured":"Kalucka J, Bierhansl L, Conchinha NV et al (2018) Quiescent endothelial cells upregulate fatty acid \u03b2-oxidation for vasculoprotection via redox homeostasis. Cell Metab 28:881\u2013894.e13","journal-title":"Cell Metab"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/s41598-020-58334-7","volume":"10","author":"Y Ma","year":"2020","unstructured":"Ma Y, Wang W, Devarakonda T et al (2020) Functional analysis of molecular and pharmacological modulators of mitochondrial fatty acid oxidation. Sci Rep 10:1450","journal-title":"Sci Rep"},{"key":"5_CR48","unstructured":"National Center for Biotechnology Information. PubChem Database. Palmitic acid, CID=985 https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/985"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1021\/jm100809g","volume":"54","author":"SM Ceccarelli","year":"2011","unstructured":"Ceccarelli SM, Chomienne O, Gubler M, Arduini A (2011) Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research. J Med Chem 54:3109\u20133152","journal-title":"J Med Chem"},{"key":"5_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2003782","volume":"16","author":"CH Yao","year":"2018","unstructured":"Yao CH, Liu GY, Wang R et al (2018) Identifying off-target effects of etomoxir reveals that carnitine palmitoyltransferase i is essential for cancer cell proliferation independent of \u03b2-oxidation. PLoS Biol 16:e2003782","journal-title":"PLoS Biol"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cmet.2018.06.001","volume":"28","author":"AS Divakaruni","year":"2018","unstructured":"Divakaruni AS, Hsieh WY, Minarrieta L et al (2018) Etomoxir inhibits macrophage polarization by disrupting CoA homeostasis. Cell Metab 28:490\u2013503.e7","journal-title":"Cell Metab"}],"updated-by":[{"DOI":"10.1007\/978-1-0716-2128-8_27","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000}}],"container-title":["Methods in Molecular Biology","Non-Alcoholic Steatohepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2128-8_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:06:49Z","timestamp":1666570009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2128-8_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071621271","9781071621288"],"references-count":51,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2128-8_5","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"25 February 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"25 February 2022","order":2,"name":"change_date","label":"Change Date","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"In the original version of this book, the title of chapter 5 was incorrectly mentioned by the publisher. This has been rectified in the updated version of this book.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}